Ledger.Open graph →
SEC Form D · filed April 11, 2014

Cellular Biomedicine Group, Inc

Offering
$7.0M
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Keith Wong · Palo Alto, CADirectorAndrew Chan · Palo Alto, CAExecJainping Dai · Palo Alto, CADirectorWei (William) Cao · Palo Alto, CAExec · DirectorWen Tao (Steve) Liu · Palo Alto, CADirectorNadir A. Patel · Palo Alto, CADirectorTerry A. Belmont · Palo Alto, CADirectorDavid E. Snyder · Newport Beach, CAExecStacie K. Yamane · Newport Beach, CADirectorPeter M. Bren · Newport Beach, CAExec · DirectorBrian W. Throckmorton · London, OHDirectorRobert W. Antablin · New York, NYDirectorJeff Auerbach · Palo Alto, CADirectorGerardus A. Hoogland · Palo Alto, CADirectorTerry A. Belmont · Cupertino, CADirectorDavid Bolocan · Palo Alto, CADirectorBizou (Tony) Liu · Palo Alto, CADirectorNadir A. Patel · Cupertino, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗